Literature DB >> 21475309

Immunological biomarkers of tuberculosis.

Gerhard Walzl1, Katharina Ronacher, Willem Hanekom, Thomas J Scriba, Alimuddin Zumla.   

Abstract

Currently there are no sufficiently validated biomarkers to aid the evaluation of new tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the development of more effective and shorter treatment regimens. To date, the detection of Mycobacterium tuberculosis or its products has not been able to adequately address these needs. Understanding the interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches. Here, we review immunological markers, their relation to M. tuberculosis infection stages and their potential use in the fight against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475309     DOI: 10.1038/nri2960

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  99 in total

Review 1.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Thorax       Date:  2007-08-03       Impact factor: 9.139

2.  Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.

Authors:  Pramod K Giri; Indu Verma; Gopal K Khuller
Journal:  FEMS Immunol Med Microbiol       Date:  2006-07

Review 3.  Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Authors:  Karen R Steingart; Nandini Dendukuri; Megan Henry; Ian Schiller; Payam Nahid; Philip C Hopewell; Andrew Ramsay; Madhukar Pai; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

4.  Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.

Authors:  M Jacobsen; D Repsilber; K Kleinsteuber; A Gutschmidt; S Schommer-Leitner; G Black; G Walzl; S H E Kaufmann
Journal:  Clin Microbiol Infect       Date:  2010-07-29       Impact factor: 8.067

5.  Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.

Authors:  Jorge Antonio Esquivel-Valerio; Luis Felipe Flores-Suárez; Jacqueline Rodríguez-Amado; Mario Alberto Garza-Elizondo; Adrián Rendón; Mario Cesar Salinas-Carmona
Journal:  Clin Exp Rheumatol       Date:  2010 Jan-Feb       Impact factor: 4.473

6.  Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells.

Authors:  M M Thomas; T S C Hinks; S Raghuraman; N Ramalingam; M Ernst; R Nau; C Lange; K Kösters; C Gnanamuthu; G T John; B Marshall; A Lalvani
Journal:  Int J Tuberc Lung Dis       Date:  2008-06       Impact factor: 2.373

7.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

8.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

9.  Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach.

Authors:  Dirk Repsilber; Sabine Kern; Anna Telaar; Gerhard Walzl; Gillian F Black; Joachim Selbig; Shreemanta K Parida; Stefan H E Kaufmann; Marc Jacobsen
Journal:  BMC Bioinformatics       Date:  2010-01-14       Impact factor: 3.169

10.  Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report.

Authors:  Novel N Chegou; Gillian F Black; Martin Kidd; Paul D van Helden; Gerhard Walzl
Journal:  BMC Pulm Med       Date:  2009-05-16       Impact factor: 3.317

View more
  202 in total

1.  Multicytokine detection improves latent tuberculosis diagnosis in health care workers.

Authors:  Pierre-Alain Rubbo; Nicolas Nagot; Vincent Le Moing; Marylène Brabet; Arnaud Bourdin; Erika Nogué; Karine Bolloré; Jean-Pierre Vendrell; Philippe Van De Perre; Edouard Tuaillon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Commonly administered bacille Calmette-Guerin strains induce comparable immune response.

Authors:  Jun-Fang Wang; Fu-Ying Dai; Xue-Li Gong; Lang Bao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

4.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

5.  Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.

Authors:  Albanus O Moguche; Munyaradzi Musvosvi; Adam Penn-Nicholson; Courtney R Plumlee; Helen Mearns; Hennie Geldenhuys; Erica Smit; Deborah Abrahams; Virginie Rozot; One Dintwe; Søren T Hoff; Ingrid Kromann; Morten Ruhwald; Peter Bang; Ryan P Larson; Shahin Shafiani; Shuyi Ma; David R Sherman; Alessandro Sette; Cecilia S Lindestam Arlehamn; Denise M McKinney; Holden Maecker; Willem A Hanekom; Mark Hatherill; Peter Andersen; Thomas J Scriba; Kevin B Urdahl
Journal:  Cell Host Microbe       Date:  2017-06-14       Impact factor: 21.023

6.  A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis.

Authors:  Xun Liu; Jinxiu Peng; Lina Hu; Yanping Luo; Hongxia Niu; Chunxiang Bai; Qian Wang; Fei Li; Hongjuan Yu; Bingxiang Wang; Huiyu Chen; Ming Guo; Bingdong Zhu
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

7.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

Review 8.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

9.  Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.

Authors:  Ying Xu; Enzhuo Yang; Jianguang Wang; Rui Li; Guanghua Li; Guoyuan Liu; Na Song; Qi Huang; Cong Kong; Honghai Wang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 10.  Recent advances in the development of vaccines for tuberculosis.

Authors:  Mohamed Jawed Ahsan
Journal:  Ther Adv Vaccines       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.